Roche v Cipla: Part 1: Validity of Patent
26th September, 2012 - 7:53 am
Categories:
IP Litigation
IP Practice in India
News & Updates
Pharma/Biotech Patent Litigations
0 Comments
In continuation of our previous post here, and following the availability of the 275 page judgement, we would discuss herein the various facets of the case and discuss one by one. This case actually involved two main issues as follows, Issue I. Whether Roche’s Indian Patent 196774 is invalid (liable to be revoked under S. … Continue reading Roche v Cipla: Part 1: Validity of Patent
Read more »What’s in a domain name?
The original role of having a domain name was to provide an internet address for computers. With the increasing rate of commercial activities on the web, a domain name is now seen as a way of identifying the business of the company. A potential consumer is always lured to the company after he/she goes through … Continue reading What’s in a domain name?
Read more »Cipla won the landmark Roche v Cipla Litigation
8th September, 2012 - 10:46 am
Categories:
IP Practice in India
News & Updates
Pharma/Biotech Patent Litigations
0 Comments
Indian Generic manufacturer Cipla has won the landmark Roche v. Cipla Patent Infringement case in the Delhi High Court over Cipla’s Generic version of Anti-cancer Drug Erlotinib. The case is the first Patent Litigation in India post India’s 2005 Product Patent Regime which included public interest and pricing issues in addition to India’s Section 3d … Continue reading Cipla won the landmark Roche v Cipla Litigation
Read more »